Chlamydia screening can have high take-up rates if right methodology is used

doi:10.1136/bmj.319.7203.188b

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

John Macleod, Clinical research fellow,
George Davey Smith, Professor of clinical epidemiology

Department of General Practice, University of Birmingham, Birmingham B15 2TT
Department of Social Medicine, University of Bristol, Bristol BS8 2PR

EDITOR—A report by the expert advisory group to the chief medical officer suggested that a screening programme in the United Kingdom for Chlamydia trachomatis should be based around the opportunistic testing of women attending primary care and the tracing of their contacts.1 Duncan and Hart discuss some of the possible negative consequences of this decision.2 There are some further reasons why the Department of Health's stated strategy is a bad idea.

Chlamydia screening has …